Literature DB >> 2984623

Studies on cataractogenesis in humans and in rats with alloxan-induced diabetes. II. Histochemical evaluation of lenticular enzymes.

S S Ahmad, K C Tsou, S I Ahmad, M A Rahman.   

Abstract

The effect of cataractogenesis on the behavior of some enzymes involved in glucose metabolism was examined histochemically both in human lenses and in rat lenses from rats with alloxan-induced diabetes. Several modifications in the currently available techniques were made in order to localize glucose-6-phosphate dehydrogenase, aldose reductase, sorbitol dehydrogenase, hexokinase and ketohexokinase in ocular lens. Human cataractous lenses showed a precipitous drop in glucose-6-phosphate dehydrogenase activity, whereas the lenticular tissues of alloxan-treated rats showed a gradual decrease of this enzyme with the prolongation of diabetes. Aldose reductase activity increased in hypermature and senile diabetic cataracts, whereas sorbitol dehydrogenase activity decreased in these lenses. Similarly, in alloxan-diabetic rat lenses the activity of aldose reductase increased while that of sorbitol dehydrogenase decreased with the prolongation of diabetes. Attempts were made to localize hexokinase and ketohexokinase in ocular lens.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2984623     DOI: 10.1159/000265344

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  2 in total

1.  A proteomic approach to identify early molecular targets of oxidative stress in human epithelial lens cells.

Authors:  Igor Paron; Angela D'Elia; Chiara D'Ambrosio; Andrea Scaloni; Federica D'Aurizio; Alan Prescott; Giuseppe Damante; Gianluca Tell
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

2.  Astaxanthin from shrimp by-products ameliorates nephropathy in diabetic rats.

Authors:  Assaâd Sila; Zohra Ghlissi; Zeineb Kamoun; Mohamed Makni; Moncef Nasri; Ali Bougatef; Zouheir Sahnoun
Journal:  Eur J Nutr       Date:  2014-05-13       Impact factor: 5.614

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.